Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints
Titel:
Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints
Auteur:
Patoulias, D. Katsimardou, A. Kalogirou, M.-S. Zografou, I. Toumpourleka, M. Imprialos, K. Stavropoulos, K. Stergiou, I. Papadopoulos, C. Doumas, M.